Targeting the HuR Oncogenic Role with a New Class of Cytoplasmic Dimerization Inhibitors.
Filippova N, Yang X, Ananthan S, Calano J, Pathak V, Bratton L, Vekariya RH, Zhang S, Ofori E, Hayward EN, Namkoong D, Crossman DK, Crowley MR, King PH, Mobley J, Nabors LB.
Filippova N, et al. Among authors: yang x.
Cancer Res. 2021 Apr 15;81(8):2220-2233. doi: 10.1158/0008-5472.CAN-20-2858. Epub 2021 Feb 18.
Cancer Res. 2021.
PMID: 33602784
Free PMC article.